No takes yet. Share an insight, caveat, or question.
Narrative review reveals actionable genomic alterations and novel targeted therapies in salivary gland carcinomas, suggesting precision oncology improves recurrent and metastatic disease outcomes.
Cheo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: